Applications of (S)-(+)-Phenylsuccinic Acid in Industrial Manufacturing

As a direct manufacturer of (S)-(+)-Phenylsuccinic Acid, we support multiple high-value downstream sectors where chiral intermediates and aromatic dicarboxylic acid derivatives play a crucial role in advanced synthesis. The following application sections detail real industrial integration, compliance requirements, process touchpoints, and finished product categories where our material performs critical functions at scale.

1. Pharmaceutical Chiral Building Block for API Synthesis

Pharmaceutical manufacturers engage this material as a chiral starting intermediate for stereoselective synthesis of active pharmaceutical ingredients (APIs), particularly in the cardiovascular and CNS therapeutic classes. The enantiomeric purity and controlled impurity profile support its use in multi-step hydrogenation or coupling reactions. Custom process validation often determines adaptation to either early or late-stage intermediate steps, with strict control to maintain chiral configuration and ensure full traceability in GMP environments.

Industry compliance standards

• ICH Q7 Guidelines for Good Manufacturing Practice
• USP/NF Monographs where applicable
• 21 CFR Part 210/211 for finished drug manufacturing
• EMA Guideline on the Specification Limits for Residues of Metal Catalysts

Typical usage ratio

• Used at 0.5–3.5 parts by weight per part of target API (w/w), dependent on route, yield optimization, and purity needs

Downstream process integration

• Introduced following initial aromatic substitution or esterification
• Acts as a chiral auxiliary or reactant for asymmetric coupling and ring-closure steps
• Subjected to intermediate purification and in-process chiral HPLC control
• Transitions into protected intermediate formulations for API assembly

Final product types

• Active pharmaceutical ingredients, e.g., antihypertensive and antiepileptic agents
• Regulated pharmaceutical intermediates
• Chiral reference standards and research compounds
• Generic and branded drug substances

2. Advanced Agrochemical Synthesis Intermediates

Agrochemical producers utilize our material as a key synthon in the construction of selective chiral herbicides and fungicides. The acid’s asymmetric properties enable stereospecific catalytic and acylation steps, supporting residue safety demands in regulated markets. Applications include enantioselective formulation of multi-ring pesticides and derivatives that exhibit enhanced field activity with minimized off-target toxicity.

Industry compliance standards

• FAO/WHO Food and Agriculture Organization Specifications
• REACH Registration, Evaluation, Authorization and Restriction of Chemicals (EC No 1907/2006)
• ISO 9001:2015 certified processes
• GLP (Good Laboratory Practice) for regulatory submissions

Typical usage ratio

• Incorporated at 1–10% by mass in batch synthesis, dependent on target chiral loading and crop safety regulatory restrictions

Downstream process integration

• Added post-initial nitration or amidation stages
• Feeds directly into esterification or etherification columns for ester/ether pesticides
• Chirality confirmed by GC or HPLC with polarimetric endpoints
• Processed through distillation before formulation blending

Final product types

• Chiral herbicides for cereals and pulses
• Enantiomeric fungicides for vegetable crops
• Active intermediates for crop protection agent synthesis
• Custom synthesized test chemicals for agriscience R&D

3. Specialty Polymer Monomer for Optical Materials

Manufacturers in the specialty polymer sector employ this material as a monomeric component during polycondensation to impart specific chiral optic activity or adjust crystallinity in functional resins. The orientation and rigidity of its aromatic and succinyl backbone allow tailoring of polymer chain behavior, supporting light transmission, and polarization in advanced optical films. Integrators require trace metal and residual solvent levels far below standard industrial limits to avoid optical haze and maintain film integrity.

Industry compliance standards

• RoHS Directive (2011/65/EU, including 2015 amendment)
• ISO 14001 Environmental Management for polymer facilities
• UL 94 flammability rating for films when required
• REACH Annex XVII restricted substances check for additive compatibility

Typical usage ratio

• 1–8 mol% relative to base diacid/dialcohol stream, varied on target refractive index and chiral induction result

Downstream process integration

• Charged into monomer feed at controlled temperature pre-polymerization
• Participates in melt-phase or solution polycondensation
• Chiral induction measured by plane-polarized light during QC
• Blended with plasticizers or co-monomers for final adjustment

Final product types

• Optical films for LCD and OLED displays
• Polarizing sheets for imaging devices
• Chiral indicator polymers for analytical use
• Specialty resins for laser or photonic applications

4. Fine Chemical Intermediate for Enantioselective Synthesis

Producers of analytical standards and custom molecules utilize our chiral acid as a modular intermediate for crafting high-purity compounds required in enantiomerically precise research and measurement. Laboratories and pilot-scale syntheses leverage its well-defined stereochemistry for aldol, Michael, and Diels–Alder reactions, where reversal or loss of configuration directly impairs end-use validity. Specification demands focus on minimized racemization and contamination over multiple scale-up cycles.

Industry compliance standards

• ISO/IEC 17025 for analytical laboratories
• GMP for reference standard suppliers according to regional guidelines
• FDA Audit requirements for quality incidents
• Chemical Facility Anti-Terrorism Standards (CFATS, USA) for precursor storage

Typical usage ratio

• 0.2–2.5 equivalents in molar ratio to limiting reactant, adjusted for enantiopurity and scale

Downstream process integration

• Introduced as a substrate in initial chiral condensation or ring-forming steps
• Reacts with organometallics or amines to form advanced intermediates
• Subject to repeated recrystallization and purity verification
• Packed for onward shipment as high-value chiral intermediates

Final product types

• Enantiopure research reagents
• Certified analytical standards for HPLC/GC-MS
• Custom fine chemicals for peptide or catalyst synthesis
• Stereochemically defined reference compounds for academia and industry